Annals of the Rheumatic Diseases

Low uveitis rates in patients with axial spondyloarthritis treated with bimekizumab: pooled results from phase 2b/3 trials.

Annals of the Rheumatic Diseases

Brown MA, Rudwaleit M, van Gaalen FA, Haroon N, Gensler LS, Fleurinck C, Marten A, Massow U, de Peyrecave N, Vaux T, White K, Deodhar A, van der Horst-Bruinsma I

POS0806 LONG-TERM SUSTAINED EFFICACY AND SAFETY OF BIMEKIZUMAB ACROSS THE FULL SPECTRUM OF AXIAL SPONDYLOARTHRITIS: 2-YEAR RESULTS FROM TWO PHASE 3 STUDIES.

Annals of the Rheumatic Diseases

X. Baraliakos, A. Deodhar, D. Van der Heijde, F. Van den Bosch, M. Magrey, W.P. Maksymowych, T. Tomita, H. Xu, U. Massow, C. Fleurinck, T. Vaux, C. Prajapati, J. Shepherd-Smith, A. Marten, L.S. Gensler

POS0194 FACTORS ASSOCIATED WITH RADIOGRAPHIC SPINAL PROGRESSION IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS RECEIVING IL-17A INHIBITOR OR TNF INHIBITOR THERAPY: A POST-HOC ANALYSIS OF THE SURPASS STUDY.

Annals of the Rheumatic Diseases

D. Poddubnyy, J. Braun, P. Machado, V. Navarro-Compán, L.S. Gensler, K.G. Hermann, E. Quebe-Fehling, C.C. Pieterse, A. Readie, C. Gaillez, X. Baraliakos

AB0881 LONG-TERM SAFETY AND TOLERABILITY OF BIMEKIZUMAB IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS AND PSORIATIC ARTHRITIS: RESULTS FROM POOLED PHASE 2B/3 STUDIES.

Annals of the Rheumatic Diseases

P.J. Mease, D. Poddubnyy, A.M. Orbai, R.B. Warren, C. Fleurinck, R. Bajracharya, B. Ink, U. Massow, V. Shende, J. Shepherd-Smith, L. Peterson, K. White, R. Landewé, L.S. Gensler

POS0391 THE MSQUASH AS MEASUREMENT TOOL FOR DAILY PHYSICAL ACTIVITY: TRANSLATION AND CROSS-CULTURAL ADAPTATION INTO ENGLISH, FIELD-TESTING IN DIFFERENT RHEUMATIC DISEASES AND CLINICAL VALIDATION IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS.

Annals of the Rheumatic Diseases

Y.M. Van der Kraan, L.S. Gensler, D. Paap, E. Thovmasyan, N.S. Ausma, H. Kokol, M. Carbo, K. De Leeuw, K. Van der Geest, H. Bootsma, J.P.L. Spoorenberg, S. Arends

POS0215 LONG-TERM SAFETY AND EFFICACY OF BIMEKIZUMAB IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS: 5-YEAR RESULTS FROM A PHASE 2B STUDY AND ITS OPEN-LABEL EXTENSION.

Annals of the Rheumatic Diseases

A. Deodhar, V. Navarro-Compán, D. Poddubnyy, L.S. Gensler, S. Ramiro, T. Tomita, H. Marzo-Ortega, C. Fleurinck, T. Vaux, U. Massow, D. Van der Heijde, X. Baraliakos

AB0913 EFFICACY OF CERTOLIZUMAB PEGOL IN PREVENTING ANTERIOR UVEITIS FLARES COMPARED WITH STANDARD NON-BIOLOGIC TREATMENT: A MATCHED CONTROL STUDY IN HIGH-RISK PATIENTS WITH AXIAL SPONDYLOARTHRITIS.

Annals of the Rheumatic Diseases

N. Haroon, Z. Baskurt, T. Chim, R. Inman, D. Paez, T. Kumke, R. Tham, M. Kim, I. Van der Horst-Bruinsma, L.S. Gensler

Goodbye to the term 'ankylosing spondylitis', hello 'axial spondyloarthritis': time to embrace the ASAS-defined nomenclature.

Annals of the Rheumatic Diseases

van der Heijde D, Molto A, Ramiro S, Braun J, Dougados M, van Gaalen FA, Gensler LS, Inman RD, Landewé RBM, Marzo-Ortega H, Navarro-Compán V, Phoka A, Poddubnyy D, Protopopov M, Reveille J, Rudwaleit M, Sampaio-Barros P, Sepriano A, Sieper J, Van den Bosch FE, van der Horst-Bruinsma I, Machado PM, Baraliakos X

Goodbye to the term ‘ankylosing spondylitis’, hello ‘axial spondyloarthritis’: time to embrace the ASAS-defined nomenclature.

Annals of the Rheumatic Diseases

Désirée van der Heijde, Anna Molto, Sofia Ramiro, Jürgen Braun, Maxime Dougados, Floris A van Gaalen, Lianne S Gensler, Robert D Inman, Robert B M Landewé, Helena Marzo-Ortega, Victoria Navarro-Compán, Andri Phoka, Denis Poddubnyy, Mikhail Protopopov, John Reveille, Martin Rudwaleit, Percival Sampaio-Barros, Alexandre Sepriano, Joachim Sieper, Filip E Van den Bosch, Irene van der Horst-Bruinsma, Pedro M Machado, Xenofon Baraliakos

Bimekizumab treatment in patients with active axial spondyloarthritis: 52-week efficacy and safety from the randomised parallel phase 3 BE MOBILE 1 and BE MOBILE 2 studies.

Annals of the Rheumatic Diseases

Baraliakos X, Deodhar A, van der Heijde D, Magrey M, Maksymowych WP, Tomita T, Xu H, Massow U, Fleurinck C, Ellis AM, Vaux T, Shepherd-Smith J, Marten A, Gensler LS

Pages